Cerebrolysin is a neurometabolic stimulator based on neuropeptides (20 percent) and amino acids (80 percent) isolated from pig brain tissue. It was developed in 1949 by Gerhart Harrer, an Austrian professor, and approved on August 1, 1954.
Unlike most peptides, Cerebrolysin has all the amino acids which support the functioning of the central nervous system, and this can explain many of its positive properties.
Like Semax, it is on the Russian list of ‘essential medicines’ and is used as a treatment for various cerebral disorders in 44 countries, mostly in Europe and Asia.
Used as a treatment for:
Cerebrolysin, 5 ampoules (10ml each)
This product has not been evaluated by the FDA and is not intended to diagnose, cure, or prevent any disease.
Safety Information: Keep this product out of the reach of children. This product is not a dietary supplement. It is a research compound, sold as a raw material. It may result in adverse effects if improperly handled or consumed. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material.
Cymnootropics.com can’t be held responsible for any adverse effects that may arise from improper handling and/or consumption of this product.
Subscribe and receive news about our special sales and coupons